<?xml version="1.0" encoding="UTF-8"?><mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="id-2018-05687">
    <name type="corporate">
        <namePart>United States Government Publishing Office</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
            <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
        <role>
            <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
            <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>National Archives and Records Administration</namePart>
        <namePart>Office of the Federal Register</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">author</roleTerm>
            <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
        <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
        <collectionCode>FR</collectionCode>
        <category>Regulatory Information</category>
        <waisDatabaseName>2018_register</waisDatabaseName>
        <branch>executive</branch>
        <dateIngested>2018-03-21</dateIngested>
    </extension>
    <genre authority="marcgt">article</genre>
    <titleInfo>
        <title>Postmarketing Safety Reporting for Combination Products; Draft Guidance for Industry and Food and Drug Administration Staff; Availability</title>
        <partName>Proposed Rules</partName>
    </titleInfo>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2018-03-21/html/2018-05687.htm">
        <identifier type="FDsys Unique ID">D09002ee1c7ea339f</identifier>
    </relatedItem>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2018-03-21/pdf/2018-05687.pdf">
        <identifier type="FDsys Unique ID">D09002ee1c7ea34b4</identifier>
    </relatedItem>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Department of Health and Human Services</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Food and Drug Administration</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <abstract>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry and FDA staff entitled "Postmarketing Safety Reporting for Combination Products." This draft guidance addresses certain means by which applicants may comply with the final rule on postmarketing safety reporting (PMSR) requirements for combination products that FDA issued on December 20, 2016. Combination products are products composed of two or more different types of medical products (drug, device, and/or biological product). Although the PMSR regulations for drugs, devices, and biological products share many similarities, each set of regulations establishes distinct postmarketing reporting requirements, standards, and timeframes. The final rule provides clarity on the PMSR requirements for combination products to ensure consistent and complete reporting while avoiding duplication. This draft guidance is not final nor is it in effect at this time.</abstract>
    <identifier type="FR citation">83 FR 12292</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/FR-2018-03-21/2018-05687</identifier>
    <identifier type="FR Doc No.">2018-05687</identifier>
    <identifier type="former granule identifier">fr21mr18-21</identifier>
    <identifier type="billing code">4164-01-P</identifier>
    <identifier type="department code">Docket No. FDA-2008-N-0424</identifier>
    <location>
        <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2018-03-21/2018-05687</url>
        <url access="raw object" displayLabel="HTML rendition">https://www.govinfo.gov/content/pkg/FR-2018-03-21/html/2018-05687.htm</url>
        <url access="raw object" displayLabel="PDF rendition">https://www.govinfo.gov/content/pkg/FR-2018-03-21/pdf/2018-05687.pdf</url>
    </location>
    <physicalDescription>
        <extent>3 p.</extent>
    </physicalDescription>
    <part type="Proposed Rules">
        <extent unit="pages">
            <start>12292</start>
            <end>12294</end>
        </extent>
    </part>
    <identifier type="preferred citation">83 FR 12292</identifier>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 4</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  4</identifier>
    </relatedItem>
    <extension>
        <searchTitle>Postmarketing Safety Reporting for Combination Products; Draft Guidance for Industry and Food and Drug Administration Staff; Availability; Federal Register Vol. 83, Issue </searchTitle>
        <granuleClass>PRORULE</granuleClass>
        <accessId>2018-05687</accessId>
        <agency order="1">DEPARTMENT OF HEALTH AND HUMAN SERVICES</agency>
        <agency order="2">Food and Drug Administration</agency>
        <commentDate>2018-06-19</commentDate>
        <departmentDoc>Docket No. FDA-2008-N-0424</departmentDoc>
        <billingCode>4164-01-P</billingCode>
        <frDocNumber>2018-05687</frDocNumber>
        <action>Notification of availability.</action>
        <summary>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry and FDA staff entitled "Postmarketing Safety Reporting for Combination Products." This draft guidance addresses certain means by which applicants may comply with the final rule on postmarketing safety reporting (PMSR) requirements for combination products that FDA issued on December 20, 2016. Combination products are products composed of two or more different types of medical products (drug, device, and/or biological product). Although the PMSR regulations for drugs, devices, and biological products share many similarities, each set of regulations establishes distinct postmarketing reporting requirements, standards, and timeframes. The final rule provides clarity on the PMSR requirements for combination products to ensure consistent and complete reporting while avoiding duplication. This draft guidance is not final nor is it in effect at this time.</summary>
        <dates>Submit either electronic or written comments on the draft guidance by June 19, 2018 to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance.</dates>
        <contact>Melissa Burns, Office of Combination Products, Food and Drug Administration, 301-796-5616, melissa.burns@fda.hhs.gov.</contact>
        <cfr title="21">
                                    
            <part number="4"/>
                                
        </cfr>
        <tocSubject1>Guidance:</tocSubject1>
        <tocDoc>Postmarketing Safety Reporting for Combination Products
, </tocDoc>
        <emailRef>melissa.burns@fda.hhs.gov</emailRef>
        <urlRef>https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm109110.htm</urlRef>
        <urlRef>https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf</urlRef>
        <urlRef>https://www.regulations.gov</urlRef>
    </extension>
    <relatedItem type="host" ID="P0b002ee199bcd0de" xlink:href="https://www.govinfo.gov/metadata/pkg/FR-2018-03-21/mods.xml">
        <titleInfo>
            <title>Federal Register</title>
            <partNumber>Vol. 83, no. 55</partNumber>
        </titleInfo>
        <originInfo>
            <publisher>Office of the Federal Register, National Archives and Records Administration</publisher>
            <dateIssued encoding="w3cdtf">2018-03-21</dateIssued>
            <issuance>continuing</issuance>
            <frequency>daily</frequency>
        </originInfo>
        <physicalDescription>
            <note type="source content type">deposited</note>
            <digitalOrigin>born digital</digitalOrigin>
            <extent>237 p.</extent>
        </physicalDescription>
        <tableOfContents xlink:href="https://www.govinfo.gov/app/frtoc/2018-03-21">    
		  Table of Contents: 
		</tableOfContents>
        <classification authority="sudocs">AE 2.7:</classification>
        <classification authority="sudocs">GS 4.107:</classification>
        <classification authority="sudocs">AE 2.106:</classification>
        <classification authority="lcc">KF70.A2</classification>
        <identifier type="uri">https://www.govinfo.gov/app/details/FR-2018-03-21</identifier>
        <identifier type="local">P0b002ee199bcd0de</identifier>
        <identifier type="issn">0097-6326</identifier>
        <identifier type="issn">0042-1219</identifier>
        <identifier type="issn">0364-1406</identifier>
        <identifier type="stock number">769-004-00000-9</identifier>
        <identifier type="ILS system id">000582072</identifier>
        <identifier type="former identifier">f:fr21mr18</identifier>
        <location>
            <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2018-03-21</url>
            <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2018-03-21/pdf/FR-2018-03-21.pdf</url>
            <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2018-03-21/xml/FR-2018-03-21.xml</url>
        </location>
        <accessCondition type="GPO scope determination">fdlp</accessCondition>
        <part type="issue">
            <extent unit="pages">
                <start>12243</start>
                <end>12470</end>
            </extent>
        </part>
        <recordInfo>
            <recordContentSource authority="marcorg">DGPO</recordContentSource>
            <recordCreationDate encoding="w3cdtf">2018-03-21</recordCreationDate>
            <recordChangeDate encoding="w3cdtf">2024-06-01</recordChangeDate>
            <recordIdentifier source="DGPO">FR-2018-03-21</recordIdentifier>
            <recordOrigin>machine generated</recordOrigin>
            <languageOfCataloging>
                <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
            </languageOfCataloging>
        </recordInfo>
        <extension>
            <docClass>FR</docClass>
            <accessId>FR-2018-03-21</accessId>
            <volume>83</volume>
            <issue>55</issue>
        </extension>
    </relatedItem>
</mods>
